This book is now updated to keep you current with the latest research and trends in the field. Covering both basic science and clinical practice, this new edition draws on the talents of 53 new contributors to guarantee fresh, authoritative perspectives on advances in psychiatric drug therapy. Introductory chapters provide a theoretical grounding in clinical applications and include a new chapter on genomics and genetics. The 'Classes of Psychiatric Treatment' section is a virtual pharmacopoeia, with chapters devoted to specific agents. It presents information by class of drug; includes data on indications, side effects, and interactions for each; and features expanded coverage of newly approved agents.

Genetics promises to provide one of the most powerful approaches to understanding the functional pathology of the human brain. This book presents a critical review of the evidence for a genetic contribution to common psychiatric conditions and the rarer single-gene disorders that may have psychiatric presentations The first section of the book introduces the reader to molecular biology and the techniques of molecular genetics. The coverage then moves on to consider the genetics of normal and abnormal development, followed by a look at the genetics of abnormal behaviour in adults. This section includes, amongst others, consideration of personality disorders, schizophrenia and the dementias. The final section considers the applications of the work and covers issues such as counselling and ethics, closing with a look to the future. The editors are internationally renowned figures in this field and they have invited a team of equally eminent chapter authors. This will be essential reading for psychiatrists and geneticists and will be essential reading for psychiatrists and geneticists and will be of interest to neurologists, psychologists and neuroscientists.